Ganoderic acid C6

• Description :

  Ganoderic acid C6 has aldose reductase inhibitory activity[1].

• UNSPSC :

  12352211

• Hazard Statement :

  H302, H315, H319

• Target :

  Aldose Reductase

• Type :

  Natural Products

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Metabolism-sugar/lipid metabolism

• Field of Research :

  Metabolic Disease

• Assay Protocol :

  https://www.medchemexpress.com/ganoderic-acid-c6.html

• Purity :

  99.7

• Solubility :

  DMSO : 50 mg/mL (ultrasonic)

• Smiles :

  C[C@]12C3=C(C([C@H]([C@@]1([C@@](CC2=O)([H])[C@H](C)CC(CC(C)C(O)=O)=O)C)O)=O)[C@@]4([C@@](C(C)([C@H](CC4)O)C)([H])CC3=O)C

• Molecular Formula :

  C30H42O8

• Molecular Weight :

  530.65

• Precautions :

  H302, H315, H319

• References & Citations :

  [1]Fatmawati S, Shimizu K, Kondo R. Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors. Bioorg Med Chem Lett. 2011;21 (24) :7295-7297.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, protect from light)

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• CAS Number :

  [105742-76-5]